Total intravenous anesthesia with remifentanil and propofol for implantation of cardioverter-defibrillators in patients with severely reduced left ventricular function

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 13, Issue 1, 1999, Pages 15-19

  Lehmann, Andreas ^b   Boldt, Joachim ^a   Zeitler, Christine ^b   Thaler, Elfi ^b   Werling, Christiane ^b  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b NONE

Author keywords

Cardioverter defibrillator; Left ventricular dysfunction; Propofol; Remifentanil; TIVA

Indexed keywords

DOBUTAMINE; PIRITRAMIDE; PROPOFOL; REMIFENTANIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEFIBRILLATOR; DOSE RESPONSE; DRUG COST; EXTUBATION; FEMALE; HEALTH CARE COST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HIGH RISK POPULATION; HUMAN; INTENSIVE CARE; INTRAVENOUS ANESTHESIA; LUNG ARTERY PRESSURE; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VASCULAR RESISTANCE;

EID: 0033049720     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(99)90166-0     Document Type: Article

References (34)

1. Vuyk J: Pharmacokinetic and pharmacodynamic interactions between opioids and propofol. J Clin Anesth 9:23S-26S, 1997 (suppl 6)
2. Natale A, Kearney MM, Brandon MJ, et al: Safety of nurse-administered deep sedation for defibrillator implantation in the electrophysiology laboratory. J Cardiovasc Electrophysiol 7:301-306, 1996
3. Pacifico A, Cedillo-Salazar FR, Nasir N, et al: Conscious sedation with combined hypnotic agents for implantation of implantable cardioverter-defibrillators. J Am Coll Cardiol 30:769-773, 1997
4. Pacifico A, Wheelan KR, Nasir N, et al: Long-term follow-up of cardioverter-defibrillator implanted under conscious sedation in pectoral subfascial position. Circulation 95:946-950, 1997
5. Stix G, Anavari A, Grabenwoger M, et al: Implantation of unipolar cardioverter/defibrillator system under local anesthesia. Eur Heart J 17:764-768, 1996
6. Tung RT, Bajaj AK: Safety of implantation of a cardioverter-defibrillator without general anesthesia in an electrophysiology laboratory. Am J Cardiol 75:908-912, 1995
7. Strickberger SA, Hummel JD, Daoud E, et al: Implantation by electrophysiologists of 100 consecutive cardioverter defibrillators with nonthoracotomy lead systems. Circulation 90:868-872, 1994
8. Fitzpatrick AP, Lesh MD, Epstein LM, et al: Electrophysiological laboratory, electrophysiologist-implanted, nonthoracotomy-implantable cardioverter/defibrillators. Circulation 89:2503-2508, 1994
9. Trappe HJ, Pfitzner P, Heintze J, et al: Cardioverter-defibrillator implantation in the heart catheterization laboratory - Observations with 105 patients. Z Kardiol 84:385-393, 1995
10. Blakeman BP, Sullivan HJ, Montoya A, et al: Nonthoracotomy lead system for implantable deflbrillator. J Thorac Cardiovasc Surg 106:1040-1047, 1993
11. Westmoreland CL, Hoke JF, Sebel PS, et al: Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 79:893-903, 1993
12. Egan TD: Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal. Clin Pharmacokinet 29:80-94, 1995
13. Sebel PS, Hoke JF, Westmoreland C, et al: Histamine concentrations and hemodynamic responses after remifentanil. Anesth Analg 80:990-993, 1995
14. Glass PS: Remifentanil: A new opioid. J Clin Anesth 7:558-563, 1995
15. Kapila A, Glass PS, Jacobs JR, et al: Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 83:968-975, 1995
16. Schüttler J, Albrecht S, Breivik H, et al: A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery. Anesthesia 52:307-317, 1997
17. Dershwitz M, Randel GI, Rosow CE, et al: Initial clinical experience with remifentanil, a new opioid metabolized by esterases. Anesth Analg 81:619-623, 1995
18. Bowdle TA, Ready LB, Kharasch ED, et al: Transition to post-operative epidural or patient-controlled intravenous analgesia following total intravenous anesthesia with remifentanil and propofol for abdominal surgery. Eur J Anaesthesiol 14:374-379, 1997
19. Yarmush J, D'Angelo R, Kirkhart B, et al: A comparison of remifentanil and morphine sulfate for acute postoperative analgesia after intravenous anesthesia with remifentanil and propofol. Anesthesiology 87:235-243, 1997
20. Frame R, Brodman R, Gross J, et al: Initial experience with transvenous implantable cardioverter-defibrillator lead systems: Operative morbidity and mortality. Pacing Clin Electrophysiol 16:149-152, 1993
21. De Mulder PA, Van Kerckhoven RJ, Adriaesen HF, et al: Continuous total intravenous anesthesia, using propofol and fentanyl in an open-thorax rabbit model: Evaluation of cardiac contractile function and biochemical assessment. Lab Anim Sci 47:367-375, 1997
22. Phillips AS, McMurray TJ, Mirakhur RK, et al: Propofolfentanyl anesthesia: A comparison with isoflurane-fentanyl anesthesia in coronary artery bypass grafting and valve replacement surgery. J Cardiothorac Vase Anesth 8:289-296, 1994
23. D'Attellis N, Nicolas-Robin A, Delayance S, et al: Early extubation after mitral valve surgery: A target-controlled infusion of propofol and low-dose sufentanil. J Cardiothorac Vase Anesth 11:467-473, 1997
24. Myles PS, Buckland MR, Weeks AM, et al: Hemodynamic effects, myocardial ischemia, and timing of tracheal extubation with propofol-based anesthesia for cardiac surgery. Anesth Analg 84:12-19, 1997
25. Sherry KM, Sartain J, Bell JH, Wilkinson GA: Comparison of the use of a propofol infusion in cardiac surgical patients with normal and low cardiac output states. J Cardiothorac Vase Anesth 9:368-372, 1995
26. Vuyk J, Engbers FH, Burm AGL, et al: Pharmacodynamic interaction between propofol and alfentanil when given for induction of anesthesia. Anesthesiology 84:288-299, 1996
27. Keyl C, Tassani P, Kemkes B, et al: Hemodynamic changes due to intraoperative testing of the automatic implantable cardioverter defibrillator: Implications for anesthesia management. J Cardiothorac Vase Anesth 7:442-447, 1993
28. Izquierdo E, Matute P, Gomar C, et al: Implantable automatic cardioverter-defibrillator: Anesthesia experience. Rev Esp Anesthesiol Reanim 42:424-427, 1995
29. Hachenberg T, Hammel D, Möllhoff T, et al: Cardiopulmonary effects of internal cardioverter-defibrillator implantation. Acta Anaesthesiol Scand 35:626-630, 1991
30. Haussmann R, Polarz H, Rauch H, et al: Evoked potential monitoring during repeatedly induced ventricular fibrillation for internal defibrillator implantation. J Cardiothorac Vasc Anesth 8:61-63, 1994
31. Adams DC, Heyer EJ, Emerson RG, et al: Implantable cardioverter-defibrillator. Evaluation of clinical neurologic outcome and electroencephalographic changes during implantation. J Cardiothorac Vasc Anesth 109:565-573, 1995
32. Runsio M, Brodin LA, Eriksson L, et al: Brief episodes of ventricular fibrillation do not influence postischemic cerebral perfusion assessed by positron emission tomography. Crit Care Med 25:1827-1830, 1997
33. Hogue CW Jr, Bowdle TA, O'Leary C, et al: A multicenter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery. Anesth Analg 83:279-285, 1996
34. Wilhelm W, Huppert A, Brun K, et al: Remifentanil with propofol or isoflurane. A comparison of the recovery times after arthroscopic surgery. Anaesthesist 46:335-338, 1997